Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha–Targeting Antibody-Drug Conjugate, Potentiates the Activity of Standard of Care Therapeutics in Ovarian Cancer Models
Jose F. Ponte1, Olga Ab1, Leanne Lanieri1, Jenny Lee1, Jennifer Coccia1, Laura M. Bartle1, Marian Themeles1, Yinghui Zhou1, Jan Pinkas1, Rodrigo Ruiz-Soto1